Plant Families & their TherapeuticsPreview
Open in TheBrain

Ceftaroline

Ceftaroline is a fifth-generation cephalosporin antibiotic that has gained attention for its broad-spectrum activity, particularly against resistant strains of bacteria. It is primarily used to treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

Chemical and Pharmacological Properties

Ceftaroline is a beta-lactam antibiotic, which means it contains a beta-lactam ring in its chemical structure. This class of antibiotics works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ceftaroline is unique among cephalosporins due to its ability to bind to penicillin-binding protein 2a (PBP2a), a protein associated with methicillin-resistant Staphylococcus aureus (MRSA). This binding capability allows ceftaroline to be effective against MRSA, a significant advantage over earlier generations of cephalosporins.

Mechanism of Action

The primary mechanism of action for ceftaroline involves the inhibition of bacterial cell wall synthesis. It achieves this by binding to penicillin-binding proteins (PBPs), which are essential for the cross-linking of peptidoglycan layers in the bacterial cell wall. By binding to these proteins, ceftaroline disrupts the cell wall structure, leading to bacterial cell death. Its ability to bind to PBP2a is particularly noteworthy, as this protein is responsible for the resistance of MRSA to other beta-lactam antibiotics.

Spectrum of Activity

Ceftaroline exhibits a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. It is particularly effective against:

However, it is important to note that ceftaroline is not effective against Pseudomonas aeruginosa or Enterococcus faecium, which limits its use in certain infections.

Clinical Uses

Ceftaroline is approved for the treatment of:

  1. Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Ceftaroline is effective in treating skin infections caused by susceptible strains of bacteria, including MRSA. It is often used when other antibiotics are ineffective or when the infection is severe.
  1. Community-Acquired Bacterial Pneumonia (CABP): Ceftaroline is used to treat pneumonia caused by susceptible strains of bacteria, including drug-resistant Streptococcus pneumoniae. Its efficacy in treating CABP makes it a valuable option in the clinical setting.

Dosage and Administration

Ceftaroline is administered intravenously, typically every 12 hours. The dosage may vary based on the severity of the infection, renal function, and patient-specific factors. It is crucial to adjust the dosage in patients with renal impairment to prevent accumulation and potential toxicity.

Safety and Side Effects

Ceftaroline is generally well-tolerated, but like all antibiotics, it can cause side effects. Common side effects include:

Serious side effects are rare but can include hypersensitivity reactions, Clostridioides difficile-associated diarrhea, and hematologic abnormalities such as neutropenia. It is important to monitor patients for signs of an allergic reaction, especially those with a history of beta-lactam allergy.

Considerations and Precautions

When prescribing ceftaroline, healthcare providers should consider the following:

Attachments